$LFST
LifeStance Health Group, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024123376 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $312.7M
YoY Change 18.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $85.27M
YoY Change -34.88%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.41M
YoY Change 10.17%
% of Gross Profit
Operating Expenses $312.7M
YoY Change -7.29%
Operating Profit $47.00K
YoY Change -100.06%
Interest Expense $5.413M
YoY Change -1.17%
% of Operating Profit 11517.02%
Other Income/Expense, Net -$5.429M
YoY Change 50.35%
Pretax Income -$5.382M
YoY Change -93.1%
Income Tax $575.0K
% Of Pretax Income
Net Earnings -$5.957M
YoY Change -90.33%
Net Earnings / Revenue -1.9%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02
COMMON SHARES
Basic Shares Outstanding 382.6M 382.6M
Diluted Shares Outstanding 380.4M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $102.6M
YoY Change 140.88%
Cash & Equivalents $102.6M
Short-Term Investments
Other Short-Term Assets $26.24M
YoY Change -63.5%
Inventory
Prepaid Expenses
Receivables $158.2M
Other Receivables $0.00
Total Short-Term Assets $287.0M
YoY Change 8.62%
LONG-TERM ASSETS
Property, Plant & Equipment $170.0M
YoY Change -10.57%
Goodwill $1.293B
YoY Change -0.01%
Intangibles $195.4M
YoY Change -16.38%
Long-Term Investments
YoY Change
Other Assets $7.414M
YoY Change -43.07%
Total Long-Term Assets $1.821B
YoY Change -4.7%
TOTAL ASSETS
Total Short-Term Assets $287.0M
Total Long-Term Assets $1.821B
Total Assets $2.108B
YoY Change -3.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.282M
YoY Change -29.98%
Accrued Expenses $204.1M
YoY Change -6.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.925M
YoY Change 12.72%
Total Short-Term Liabilities $217.5M
YoY Change -9.7%
LONG-TERM LIABILITIES
Long-Term Debt $279.1M
YoY Change 12.35%
Other Long-Term Liabilities $381.0K
YoY Change -55.44%
Total Long-Term Liabilities $453.3M
YoY Change -5.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $217.5M
Total Long-Term Liabilities $453.3M
Total Liabilities $670.8M
YoY Change -6.83%
SHAREHOLDERS EQUITY
Retained Earnings -$811.2M
YoY Change 13.31%
Common Stock $2.247B
YoY Change 3.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.437B
YoY Change
Total Liabilities & Shareholders Equity $2.108B
YoY Change -3.09%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$5.957M
YoY Change -90.33%
Depreciation, Depletion And Amortization $10.41M
YoY Change 10.17%
Cash From Operating Activities $22.72M
YoY Change -189.6%
INVESTING ACTIVITIES
Capital Expenditures $5.051M
YoY Change -48.46%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$5.051M
YoY Change -48.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.025M
YoY Change 9.46%
NET CHANGE
Cash From Operating Activities 22.72M
Cash From Investing Activities -5.051M
Cash From Financing Activities -2.025M
Net Change In Cash 15.65M
YoY Change -142.28%
FREE CASH FLOW
Cash From Operating Activities $22.72M
Capital Expenditures $5.051M
Free Cash Flow $17.67M
YoY Change -150.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001845257
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40478
dei Entity Registrant Name
EntityRegistrantName
LifeStance Health Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1832801
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 N. Scottsdale Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2500
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85251
dei City Area Code
CityAreaCode
602
dei Local Phone Number
LocalPhoneNumber
767-2100
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
LFST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
382640096
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102615000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78824000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
158161000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
125405000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26244000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21502000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
287020000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
225731000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169974000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188222000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
154835000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
170703000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
195352000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
221072000
CY2024Q3 us-gaap Goodwill
Goodwill
1293346000
CY2023Q4 us-gaap Goodwill
Goodwill
1293346000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7414000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10895000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1820921000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1884238000
CY2024Q3 us-gaap Assets
Assets
2107941000
CY2023Q4 us-gaap Assets
Assets
2109969000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7282000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7051000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
111858000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
102478000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
43291000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35012000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2500000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
8169000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48959000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
46475000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3624000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3688000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
217514000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
202873000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
279055000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
280285000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
158679000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
181357000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15219000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15572000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
381000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
952000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
453334000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
478166000
CY2024Q3 us-gaap Liabilities
Liabilities
670848000
CY2023Q4 us-gaap Liabilities
Liabilities
681039000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
382640000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
382640000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
378725000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
378725000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3826000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3789000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2243673000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2183684000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
771000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2303000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-811177000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-760846000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1437093000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1428930000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2107941000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2109969000
CY2024Q3 us-gaap Revenues
Revenues
312722000
CY2023Q3 us-gaap Revenues
Revenues
262895000
us-gaap Revenues
Revenues
925490000
us-gaap Revenues
Revenues
775062000
CY2024Q3 us-gaap Other General Expense
OtherGeneralExpense
212291000
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
186686000
us-gaap Other General Expense
OtherGeneralExpense
632527000
us-gaap Other General Expense
OtherGeneralExpense
556280000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85269000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
130945000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
269356000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
317425000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15115000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19621000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
56279000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58220000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
312675000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
337252000
us-gaap Operating Expenses
OperatingExpenses
958162000
us-gaap Operating Expenses
OperatingExpenses
931925000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
47000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74357000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32672000
us-gaap Operating Income Loss
OperatingIncomeLoss
-156863000
CY2024Q3 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
15000
CY2023Q3 lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1867000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
1975000
lfst Business Combination Remeasurement Gain Loss On Contingent Consideration
BusinessCombinationRemeasurementGainLossOnContingentConsideration
4443000
CY2024Q3 lfst Transaction Costs
TransactionCosts
29000
CY2023Q3 lfst Transaction Costs
TransactionCosts
0
lfst Transaction Costs
TransactionCosts
821000
lfst Transaction Costs
TransactionCosts
89000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5413000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5477000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
17139000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15688000
CY2024Q3 us-gaap Other Expenses
OtherExpenses
2000
CY2023Q3 us-gaap Other Expenses
OtherExpenses
1000
us-gaap Other Expenses
OtherExpenses
80000
us-gaap Other Expenses
OtherExpenses
70000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5429000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3611000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16065000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11404000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5382000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77968000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48737000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-168267000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
575000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16385000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1594000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26964000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5957000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
us-gaap Net Income Loss
NetIncomeLoss
-50331000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.39
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.39
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
380359000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
380359000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372476000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
372476000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
378713000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
378713000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365556000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365556000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5957000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
us-gaap Net Income Loss
NetIncomeLoss
-50331000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1872000
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
230000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1532000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1107000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7829000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61353000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51863000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140196000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1430027000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5957000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1872000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14895000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1437093000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1494876000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-61583000
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
230000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21525000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1455048000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1428930000
us-gaap Net Income Loss
NetIncomeLoss
-50331000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1532000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
60026000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1437093000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1518723000
us-gaap Net Income Loss
NetIncomeLoss
-141303000
lfst Adoption Of Asu Two Zero One Six To One Three
AdoptionOfAsuTwoZeroOneSixToOneThree
-1948000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3399000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1107000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81868000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1455048000
us-gaap Profit Loss
ProfitLoss
-50331000
us-gaap Profit Loss
ProfitLoss
-141303000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
56279000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
58220000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
29431000
lfst Non Cash Operating Lease Costs
NonCashOperatingLeaseCosts
30225000
us-gaap Share Based Compensation
ShareBasedCompensation
60026000
us-gaap Share Based Compensation
ShareBasedCompensation
78469000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1264000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1592000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
1975000
lfst Loss Gain On Remeasurement Of Contingent Consideration
LossGainOnRemeasurementOfContingentConsideration
4443000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-998000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5105000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32757000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48484000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3924000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
52293000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
620000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3848000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9381000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7622000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-34300000
lfst Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-30109000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
10232000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
65568000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44944000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33679000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15265000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29106000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19820000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15265000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48926000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
25000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
188000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2194000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1821000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3694000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
6402000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5888000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16589000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23791000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66016000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78824000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
108621000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102615000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42605000
us-gaap Interest Paid Net
InterestPaidNet
19023000
us-gaap Interest Paid Net
InterestPaidNet
15424000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
59000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
416000
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
0
lfst Contingent Consideration Incurred In Acquisitions Of Businesses
ContingentConsiderationIncurredInAcquisitionsOfBusinesses
1985000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
1203000
lfst Purchase Of Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PurchaseOfPropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
5303000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Accounting Estimates</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make a number of estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span>
CY2024Q3 lfst Acquisition Of Non Medical Assets
AcquisitionOfNonMedicalAssets
1
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
312722000
CY2024Q3 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
262895000
CY2023Q3 lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
925490000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
775062000
lfst Revenue Recognized As Percentage Of Total Revenue
RevenueRecognizedAsPercentageOfTotalRevenue
1
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
255586000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
256906000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
85612000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68684000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169974000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
188222000
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10409000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9448000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30559000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27698000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
13817000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
14270000
us-gaap Operating Lease Cost
OperatingLeaseCost
41231000
us-gaap Operating Lease Cost
OperatingLeaseCost
42842000
us-gaap Variable Lease Cost
VariableLeaseCost
0
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0744
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0711
us-gaap Operating Lease Payments
OperatingLeasePayments
48502000
us-gaap Operating Lease Payments
OperatingLeasePayments
47356000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13752000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13844000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
12999000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
65642000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
58771000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
45104000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
32196000
CY2024Q3 lfst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
29043000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
243755000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
36117000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
207638000
CY2023Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2364000
CY2023Q3 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
1602000
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2339000
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2664000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
1610000
CY2024Q3 us-gaap Goodwill
Goodwill
1293346000
CY2023Q4 us-gaap Goodwill
Goodwill
1293346000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
171377000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
195352000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
366729000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
145657000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
221072000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4706000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10173000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25720000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30522000
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
3
CY2024Q3 lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
0
lfst Acquisitions Of Outpatient Mental Health Practices
AcquisitionsOfOutpatientMentalHealthPractices
0
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Cash
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedCash
181000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Patient Accounts Receivable
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPatientAccountsReceivable
372000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Prepaid Expenses And Other Current Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPrepaidExpensesAndOtherCurrentAssets
138000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Property And Equipment
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedPropertyAndEquipment
221000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Right Of Use Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets
368000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
22000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Intangible Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets
843000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Goodwill
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedGoodwill
20733000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Assets Acquired
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalAssetsAcquired
22878000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Total Liabilities Assumed
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedTotalLiabilitiesAssumed
893000
lfst Business Combination Fair Values Of Assets Acquired And Liabilities Assumed Fair Value Of Net Assets
BusinessCombinationFairValuesOfAssetsAcquiredAndLiabilitiesAssumedFairValueOfNetAssets
21985000
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
843000
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
86882000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
67697000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8169000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
17824000
lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
0
CY2023 lfst Business Combination Additions Related To Acquisitions
BusinessCombinationAdditionsRelatedToAcquisitions
1985000
lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-3694000
CY2023 lfst Business Combination Payments Of Contingent Consideration
BusinessCombinationPaymentsOfContingentConsideration
-7668000
lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-1975000
CY2023 lfst Business Combination Loss On Remeasurement
BusinessCombinationLossOnRemeasurement
-3972000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2500000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8169000
CY2024Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2500000
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
8169000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
287300000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
289494000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2925000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2925000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5320000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6284000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
279055000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
280285000
CY2024Q3 us-gaap Interest Expense
InterestExpense
5413000
CY2023Q3 us-gaap Interest Expense
InterestExpense
5477000
us-gaap Interest Expense
InterestExpense
17139000
us-gaap Interest Expense
InterestExpense
15688000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
731000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2925000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
2925000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2925000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
277794000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
287300000
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
306099000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
304955000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
On January 1, 2024, the number of shares of common stock reserved and available for issuance under the 2021 Equity Incentive Plan increased by 18,936 shares.
CY2024Q3 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
14895000
CY2023Q3 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
21525000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
60026000
us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
78469000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
134383000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
575000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16385000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1594000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26964000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.107
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.033
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Malpractice Insurance Coverage Floor
MalpracticeInsuranceCoverageFloor
3000000
us-gaap Malpractice Insurance Annual Coverage Limit
MalpracticeInsuranceAnnualCoverageLimit
8000000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5957000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-61583000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50331000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-141303000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
380359000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
380359000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372476000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
372476000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
378713000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
378713000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
365556000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
365556000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.13
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.39
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.39
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40522000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43200000
CY2024Q3 lfst Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
true
CY2024Q3 lfst Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
true
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
0000950170-24-123376-index-headers.html Edgar Link pending
0000950170-24-123376-index.html Edgar Link pending
0000950170-24-123376.txt Edgar Link pending
0000950170-24-123376-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lfst-20240930.htm Edgar Link pending
lfst-20240930.xsd Edgar Link pending
lfst-ex10_1.htm Edgar Link pending
lfst-ex31_1.htm Edgar Link pending
lfst-ex31_2.htm Edgar Link pending
lfst-ex32_1.htm Edgar Link pending
lfst-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lfst-20240930_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending